Overview

Losartan Effects on Emphysema Progression

Status:
Completed

Trial end date:
2021-06-30

Target enrollment:

Participant gender:

Summary

A randomized, parallel, placebo controlled trial to evaluate the effect of 100mg/day losartan on the progression of emphysema as measured by quantitative HRCT compared to placebo .

Phase:

Phase 4

Details

Lead Sponsor:

JHSPH Center for Clinical Trials
Johns Hopkins University

Collaborator:

University of Pittsburgh

Treatments:

Losartan